在帕金森综合征中胃肠道功能障碍的概述
Lauren Talman1, Delaram Safarpour1
1Department of Neurology School of Medicine, Oregon Health & Science University, Portland, Oregon.
Seminars in neurology
|September 13, 2023
概括
胃肠道功能障碍是帕金森病 (PD) 的常见早期症状,影响药物疗效和生活质量. 本综述探讨了胃肠道变化,肠道微生物群和帕金森综合征的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 胃肠道 (GI) 功能障碍是帕金森病 (PD) 和相关疾病中普遍存在的非运动性症状,通常在运动缺陷之前几年.
- 消化道的功能障碍会显著影响治疗的有效性和患者的生活质量.
- 肠道微生物群在免疫功能和神经系统调节中的作用对于理解神经退行至关重要.
结论:
- 了解胃肠道变化及其与PD的关系对于改善诊断和治疗至关重要.
- 准肠道微生物群可能为神经退行性疾病提供新的治疗途径.
- 对胃肠道症状的全面管理对于改善帕金森综合征患者的福祉至关重要.
相关概念视频
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Gastrointestinal Motility Disorders
425
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
425
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
378
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
378
Irritable Bowel Syndrome I: Introduction
311
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
311
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


